Three companies were chosen to cultivate medical marijuana in Germany – the result of a long-delayed application process to provide product for one of the largest medical cannabis markets in the world. Canada’s Aphria received five of the 13 lots that were up for grabs, according to Hendrik Knopp, managing director of Aphria Deutschland. The result […]
Aphria, Aurora and Demecan selected for German medical cannabis cultivation is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Aphria, Aurora and Demecan selected for German medical cannabis cultivation
Comments are closed, but trackbacks and pingbacks are open.